Regulation of the Immune Balance During Allogeneic Hematopoietic Stem Cell Transplantation by Vitamin D
One of the most promising therapeutic approaches for numerous hematological malignancies represents the allogeneic hematopoietic stem cell transplantation (allo-HSCT). One major complication is the development of the life-threatening graft-vs.-host disease (GvHD) which limits beneficial effects of g...
Main Authors: | Cindy Flamann, Katrin Peter, Marina Kreutz, Heiko Bruns |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.02586/full |
Similar Items
-
Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
by: Martin eSzyska, et al.
Published: (2016-03-01) -
Editorial: Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
by: Dominik Schneidawind, et al.
Published: (2020-03-01) -
The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review
by: Robert Puckrin, et al.
Published: (2023-01-01) -
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation
by: Mauro Di Ianni, et al.
Published: (2024-01-01) -
Editorial: Pathogenesis and Therapy of Graft-versus-Host Disease
by: Brian C. Betts, et al.
Published: (2019-07-01)